A Phase 1 Study of MABp1 in Patients With Advanced Cancers.

Trial Profile

A Phase 1 Study of MABp1 in Patients With Advanced Cancers.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Jan 2016

At a glance

  • Drugs MABp1 (Primary)
  • Indications Cachexia; Cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors XBiotech
  • Most Recent Events

    • 22 Jan 2016 Positive results will be presented at the American Society of Clinical Oncology (ASCO) 2016 Gastrointestinal Cancers Symposium in San Francisco, as per XBiotech media release.
    • 01 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top